consumer genomics

23andMe customers who have one of three common variants identified in reports can choose six family members to receive health and ancestry test kits.

Patients within the project and their physicians will be able to access Genome Medical's genetic specialists to address concerns and incorporate genetic information into care.

In an effort to lift patient access barriers, the company is launching a model whereby consumers will be able to initiate test orders online.

Myriad CEO Mark Capone said earnings during the quarter exceeded expectations based on strong volume growth from hereditary cancer and new products.

The market authorization came with a number of caveats and special requirements that 23andMe must follow when selling its PGx tests to consumers.

23andMe's genetic health report is for three BRCA1 and BRCA2 mutations most commonly found in people of Ashkenazi Jewish descent.